EE03522B1 - Meetod kinoloonkarboksüülhapete ja naftüridiinkarboksüülhapete saamiseks vabade aluste kujul - Google Patents
Meetod kinoloonkarboksüülhapete ja naftüridiinkarboksüülhapete saamiseks vabade aluste kujulInfo
- Publication number
- EE03522B1 EE03522B1 EE9700290A EE9700290A EE03522B1 EE 03522 B1 EE03522 B1 EE 03522B1 EE 9700290 A EE9700290 A EE 9700290A EE 9700290 A EE9700290 A EE 9700290A EE 03522 B1 EE03522 B1 EE 03522B1
- Authority
- EE
- Estonia
- Prior art keywords
- carboxylic acids
- carboxylic acid
- acid salt
- naphthyridine
- quinolone
- Prior art date
Links
- -1 quinolone carboxylic acids Chemical class 0.000 title abstract 4
- 238000004519 manufacturing process Methods 0.000 title abstract 2
- 238000000034 method Methods 0.000 title abstract 2
- SNLMOXFUCILIPL-UHFFFAOYSA-N 1,8-naphthyridine-2-carboxylic acid Chemical class C1=CC=NC2=NC(C(=O)O)=CC=C21 SNLMOXFUCILIPL-UHFFFAOYSA-N 0.000 abstract 3
- XOQQVKDBGLYPGH-UHFFFAOYSA-N 2-oxo-1h-quinoline-3-carboxylic acid Chemical class C1=CC=C2NC(=O)C(C(=O)O)=CC2=C1 XOQQVKDBGLYPGH-UHFFFAOYSA-N 0.000 abstract 3
- 239000002244 precipitate Substances 0.000 abstract 2
- 239000002585 base Substances 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 159000000007 calcium salts Chemical class 0.000 abstract 1
- 239000012458 free base Substances 0.000 abstract 1
- 238000001556 precipitation Methods 0.000 abstract 1
- 239000000047 product Substances 0.000 abstract 1
- 239000007787 solid Substances 0.000 abstract 1
- 239000002904 solvent Substances 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
- C07D215/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Quinoline Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/452,208 US5602254A (en) | 1995-05-26 | 1995-05-26 | Method for making quinoline carboxylic acids or naphthyridine carboxylic acids in free base form |
| PCT/US1996/005899 WO1996037475A1 (en) | 1995-05-26 | 1996-04-26 | Method for making quinolone carboxylic acids or naphthyridine carboxylic acids in free base form |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| EE9700290A EE9700290A (et) | 1998-06-15 |
| EE03522B1 true EE03522B1 (et) | 2001-10-15 |
Family
ID=23795530
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EE9700290A EE03522B1 (et) | 1995-05-26 | 1996-04-26 | Meetod kinoloonkarboksüülhapete ja naftüridiinkarboksüülhapete saamiseks vabade aluste kujul |
Country Status (18)
| Country | Link |
|---|---|
| US (2) | US5602254A (et) |
| EP (1) | EP0828714B1 (et) |
| JP (1) | JPH11505835A (et) |
| AT (1) | ATE199146T1 (et) |
| CA (1) | CA2220080C (et) |
| CZ (1) | CZ289107B6 (et) |
| DE (1) | DE69611782T2 (et) |
| DK (1) | DK0828714T3 (et) |
| EE (1) | EE03522B1 (et) |
| ES (1) | ES2156277T3 (et) |
| GR (1) | GR3035818T3 (et) |
| HU (1) | HUP9901338A3 (et) |
| MX (1) | MX9708562A (et) |
| NZ (1) | NZ307053A (et) |
| PL (1) | PL184063B1 (et) |
| PT (1) | PT828714E (et) |
| SK (1) | SK282666B6 (et) |
| WO (1) | WO1996037475A1 (et) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19716684B4 (de) * | 1997-04-21 | 2009-11-26 | Deep Blue Technology Ag | Anker-/Ankerketten-Überwachungsvorrichtung |
| WO2000054811A1 (en) | 1999-03-17 | 2000-09-21 | Daiichi Pharmaceutical Co., Ltd. | Medicinal compositions |
| JPWO2006004028A1 (ja) * | 2004-07-02 | 2008-04-24 | 第一製薬株式会社 | キノロン含有医薬組成物 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS53141286A (en) * | 1977-05-16 | 1978-12-08 | Kyorin Seiyaku Kk | Novel substituted quinolinecarboxylic acid |
| DE3248507A1 (de) * | 1982-12-29 | 1984-07-05 | Bayer Ag, 5090 Leverkusen | Mikrobizide mittel auf chinoloncarbonsaeure basis |
| US4822801A (en) * | 1984-07-20 | 1989-04-18 | Warner-Lambert Company | 4-oxo-1,4-dihydroquinoline-3-carboxylic acid derivative as antibacterial agents |
| US4771054A (en) * | 1985-01-23 | 1988-09-13 | Warner-Lambert Company | Antibacterial agents |
| DE3713672A1 (de) * | 1987-04-24 | 1988-11-17 | Bayer Ag | Verfahren zur herstellung von parenteral verabreichbaren chinoloncarbonsaeuren |
| US4851418A (en) * | 1987-08-21 | 1989-07-25 | Warner-Lambert Company | Naphthyridine antibacterial agents containing an α-amino acid in the side chain of the 7-substituent |
| RO101477A2 (ro) * | 1988-06-01 | 1991-11-18 | Intreprinderea Textila, Timisoara, Judetul Timis, Ro | Procedeu de obtinere a 3,3'-imino-bis-propionamidei |
| US4950787A (en) * | 1988-08-24 | 1990-08-21 | Monsanto Company | Chemical process |
| US4867901A (en) * | 1988-08-24 | 1989-09-19 | Bosch Richard J | Improved process for reacting salts of D,L-tartaric and maleic acid in the production of ether carboxylate mixtures |
| US5290794A (en) * | 1992-10-27 | 1994-03-01 | Warner Lambert Co. | Soluble calcium lactate antibacterial complexes as non-irritating parenteral forms |
-
1995
- 1995-05-26 US US08/452,208 patent/US5602254A/en not_active Expired - Fee Related
-
1996
- 1996-04-26 DE DE69611782T patent/DE69611782T2/de not_active Expired - Fee Related
- 1996-04-26 WO PCT/US1996/005899 patent/WO1996037475A1/en not_active Ceased
- 1996-04-26 NZ NZ307053A patent/NZ307053A/xx unknown
- 1996-04-26 MX MX9708562A patent/MX9708562A/es unknown
- 1996-04-26 DK DK96913229T patent/DK0828714T3/da active
- 1996-04-26 PL PL96323527A patent/PL184063B1/pl unknown
- 1996-04-26 AT AT96913229T patent/ATE199146T1/de not_active IP Right Cessation
- 1996-04-26 EP EP96913229A patent/EP0828714B1/en not_active Expired - Lifetime
- 1996-04-26 EE EE9700290A patent/EE03522B1/et not_active IP Right Cessation
- 1996-04-26 ES ES96913229T patent/ES2156277T3/es not_active Expired - Lifetime
- 1996-04-26 CZ CZ19973667A patent/CZ289107B6/cs not_active IP Right Cessation
- 1996-04-26 CA CA002220080A patent/CA2220080C/en not_active Expired - Fee Related
- 1996-04-26 HU HU9901338A patent/HUP9901338A3/hu unknown
- 1996-04-26 SK SK1564-97A patent/SK282666B6/sk unknown
- 1996-04-26 JP JP8535671A patent/JPH11505835A/ja not_active Ceased
- 1996-04-26 PT PT96913229T patent/PT828714E/pt unknown
- 1996-09-30 US US08/723,797 patent/US5783585A/en not_active Expired - Fee Related
-
2001
- 2001-04-30 GR GR20010400666T patent/GR3035818T3/el not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| DE69611782D1 (de) | 2001-03-22 |
| CZ289107B6 (cs) | 2001-11-14 |
| WO1996037475A1 (en) | 1996-11-28 |
| PL184063B1 (pl) | 2002-08-30 |
| HUP9901338A3 (en) | 2002-10-28 |
| CZ366797A3 (cs) | 1998-05-13 |
| US5602254A (en) | 1997-02-11 |
| HUP9901338A2 (hu) | 2000-04-28 |
| GR3035818T3 (en) | 2001-07-31 |
| US5783585A (en) | 1998-07-21 |
| ES2156277T3 (es) | 2001-06-16 |
| CA2220080A1 (en) | 1996-11-28 |
| CA2220080C (en) | 2006-11-21 |
| JPH11505835A (ja) | 1999-05-25 |
| AU698104B2 (en) | 1998-10-22 |
| DE69611782T2 (de) | 2001-06-21 |
| EE9700290A (et) | 1998-06-15 |
| EP0828714B1 (en) | 2001-02-14 |
| NZ307053A (en) | 1998-12-23 |
| ATE199146T1 (de) | 2001-02-15 |
| AU5630996A (en) | 1996-12-11 |
| SK282666B6 (sk) | 2002-11-06 |
| DK0828714T3 (da) | 2001-03-26 |
| MX9708562A (es) | 1997-12-31 |
| SK156497A3 (en) | 1998-03-04 |
| PL323527A1 (en) | 1998-03-30 |
| PT828714E (pt) | 2001-05-31 |
| EP0828714A1 (en) | 1998-03-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI906438A0 (fi) | Menetelmä uusien, terapeuttisesti käyttökelpoisten A-nor-steroidi-3-karboksyylihappojohdannaisten valmistamiseksi | |
| EP1065203A3 (en) | Heterocyclic compounds as retinoic acid receptor antagonists | |
| HUT61282A (en) | Process for producing substituted pyridyl dihydroxyheptanoic acids and their salts, as well as pharmaceutical compositions comprising same | |
| IL91753A0 (en) | 7-substituted derivatives of 3,5-dihydroxyhept-6-ynoic acid,a process for the preparation thereof and pharmaceutical compositions containing them | |
| GEP19960467B (en) | Method of producing derivatives of quinoline or their pharmaceutically acceptable esters or acid-additive salts | |
| PH24199A (en) | Derivatives of quinoline carboxylic acid,pharmaceutical composition containing same and process of preparing same | |
| MY109983A (en) | Serotonin antagonists | |
| PL306198A1 (en) | Method of obtaining derivatives of 3-quinolone carboxylic acid through successive reactions occurring in a single reactor | |
| IE45439L (en) | Penicillanic acid derivatives | |
| SE8900828D0 (sv) | Antivirala och immunstimulerande farmaceutiska kompositioner samt foerfarande foer framstaellning av desamma | |
| BR9408392A (pt) | Derivados de ácidos arilacéticos e sua utilização como fungicidas | |
| NO179671C (no) | Substituerte cykloheksanderivater, anvendelse av disse for fremstilling av legemidler samt legemiddel for behandling type II diabetes og andre sykdommer | |
| ATE88344T1 (de) | Zur behandlung von neurodegenerativen erkrankungen verwendbare kynurensaeurederivate. | |
| SE8900827L (sv) | Nya foereningar av salttyp samt foerfarande foer framstaellning av desamma | |
| EE03522B1 (et) | Meetod kinoloonkarboksüülhapete ja naftüridiinkarboksüülhapete saamiseks vabade aluste kujul | |
| HUT53643A (en) | Process for producing substituted azetidinye-pyridon-carboxylic acid derivatives and pharmaceutical compositions containing them | |
| ES8407021A1 (es) | Un procedimiento para la preparacion de derivados de acido 5-oxo-2-pirrolidinpropanoico. | |
| FR2612778B1 (fr) | Nouveaux derives d'aminoquinoleine antimalarique, procede de preparation et composition pharmaceutique en contenant | |
| ATE69032T1 (de) | Verfahren zur herstellung von koernigem natriumperboratmonohydrat. | |
| MA21434A1 (fr) | Procede de preparation de derives thieno-imidazole substitues utilisables comme inhibiteurs de la secretion d'acidite gastrique. | |
| JPS6183159A (ja) | Ｎ−アセチルインドリン−２−カルボン酸のラセミ化方法 | |
| DE69416117D1 (de) | Verfahren zur herstellung von kondensierten carbapenemderivaten | |
| TH468A (th) | สารดีริเวทีฟใหม่ ฮาโลวินคาโมนและขบวนการเตรียม | |
| RU94046014A (ru) | Диаминовые соли клавулановой кислоты | |
| DE69110807D1 (de) | Verfahren zur herstellung von equimolaren salzen von asparaginsäure und magnesium, magnesiumaspartatsalz nach diesem verfahren und ihre verwendung. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| KB4A | Valid patent at the end of a year |
Effective date: 20021231 |
|
| LD4A | Amendment in the specification | ||
| KB4A | Valid patent at the end of a year |
Effective date: 20031231 |
|
| KB4A | Valid patent at the end of a year |
Effective date: 20041231 |
|
| MM4A | Lapsed by not paying the annual fees |
Effective date: 20050426 |